Daniel Gibson
Founder chez TELESIS BIO, INC.
Fortune : 46 447 $ au 31/03/2024
Profil
Daniel G.
Gibson is the founder of Telesis Bio, Inc. (founded in 2011) where he holds the title of Chief Technology Officer.
He also held the position of Vice President-DNA Technology at Viridos, Inc. from 2011 to 2018.
Additionally, he was a Professor at J.
Craig Venter Institute, Inc. Dr. Gibson holds a doctorate degree from the University of Southern California and an undergraduate degree from the State University of New York at Buffalo.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TELESIS BIO, INC.
0,35% | 01/03/2024 | 105 562 ( 0,35% ) | 46 447 $ | 31/03/2024 |
Postes actifs de Daniel Gibson
| Sociétés | Poste | Début |
|---|---|---|
| TELESIS BIO, INC. | Founder | 24/03/2011 |
Anciens postes connus de Daniel Gibson
| Sociétés | Poste | Fin |
|---|---|---|
Viridos, Inc.
 Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01/08/2018 |
J. Craig Venter Institute, Inc.
 J. Craig Venter Institute, Inc. Miscellaneous Commercial ServicesCommercial Services J. Craig Venter Institute, Inc. operates as a not-for-profit genomics research organization. It conducts research on human genomic medicine, infectious diseases, plant genomics, microbial and environmental genomics, synthetic biology and biological energy, bioinformatics, and software engineering. The firm also develops a suite of software packages for sequencing/assembly, gene finding, annotation, genome analysis, microarray data analysis and normalization, protein expression quantitation, computational management, and cloud-based bioinformatics. The company was founded by J. Craig Venter and Hamilton O. Smith in October 2006 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Formation de Daniel Gibson
| University of Southern California | Doctorate Degree |
| State University of New York at Buffalo | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TELESIS BIO, INC. | Commercial Services |
| Entreprise privées | 2 |
|---|---|
Viridos, Inc.
Viridos, Inc. Miscellaneous Commercial ServicesCommercial Services Viridos, Inc. develops and commercializes genomic-driven solutions and products. The firm's offerings are designed for application in solutions such as human health, food, water production, and environment. The company was founded by J. Craig Venter, Hamilton O. Smith, David C. Kiernan and Juan Enriquez-Cabot in February 2005 and is headquartered in La Jolla, CA. | Commercial Services |
J. Craig Venter Institute, Inc.
J. Craig Venter Institute, Inc. Miscellaneous Commercial ServicesCommercial Services J. Craig Venter Institute, Inc. operates as a not-for-profit genomics research organization. It conducts research on human genomic medicine, infectious diseases, plant genomics, microbial and environmental genomics, synthetic biology and biological energy, bioinformatics, and software engineering. The firm also develops a suite of software packages for sequencing/assembly, gene finding, annotation, genome analysis, microarray data analysis and normalization, protein expression quantitation, computational management, and cloud-based bioinformatics. The company was founded by J. Craig Venter and Hamilton O. Smith in October 2006 and is headquartered in Rockville, MD. | Commercial Services |
